Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionAnthony W.H. Chan, Philip J. Johnson, Jian‐Hong Zhong et al.|Journal of Hepatology|2018Cited by 559
The chances of hepatic resection curing hepatocellular carcinomaAlessandro Cucchetti, Philip J. Johnson, Jian‐Hong Zhong et al.|Journal of Hepatology|2019Cited by 74
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Chi Yang, Jun Zhou, Jiahong Dong et al.|Liver Cancer|2022Cited by 22
Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial.Wei Wei, Rongping Guo, Shaohua Li et al.|Journal of Clinical Oncology|2023Cited by 13